ClinicalTrials.gg
CompletedNCT03653442NIHNAHUpdated Mar 4, 2020

Non Invasive Haemodynamics in Neuraxial Anaesthesia Hypotension

An observational study in Hypotension, Controlled, Anaesthesia, Spinal and Caesarean Section, sponsored by Papa Giovanni XXIII Hospital. Completed at 1 site in Italy. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2020-03-04.

Sponsored by Papa Giovanni XXIII Hospital · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
55
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

Spinal (or neuraxial) anaesthesia is still considered the first choice technique for elective Caesarean section as simple, quick, reliable and cheap. However, this anaesthetic method can be burdened by maternal hypotension with significant maternal and foetal implications.

Read the detailed description

Hypotension induced by neuraxial anaesthesia (NA-induced hypotension) is defined as systolic blood pressure (SBP) less than 100 mmHg or a decrease of 20-30% from baseline values. The incidence of hypotension could exceed 71% and can cause, if serious and prolonged, nausea, vomiting, lost of consciousness, placental hypoperfusion and foetal acidosis.

There are two alternative hypotheses to explain why hypotension might be so commonly diagnosed after regional analgesia during labour: preload reduction theory and afterload reduction theory. A non-invasive continue haemodynamic monitoring could be useful in detecting pregnant women with a positive preoperative supine stress, at increased risk for clinically significant hypotension during Caesarean section under spinal anaesthesia. These women seem more likely to benefit from optimizing the administration of fluids and vasoconstrictors to maintain pressure and cardiac output at basal levels.

Predictors of clinical need of therapy to counteract symptomatic hypotension (dependant variable) will be sought by using regression logistic analysis. Putative variable to include in the model will be selected through clinical and statistical criteria. Univariate screening will be performed assuming the usual cut-off of p\<0,1 and taking into account the biological relevance. The final variable to challenge in the multivariate model will be selected according to the parsimony criteria in order to avoid overfitting and multicollinearity.

02

Conditions studied

  • Hypotension, Controlled
  • Anaesthesia, Spinal
  • Caesarean Section

Browse trials for

Keywords

  • Induced hypotension
  • Spinal Anaesthesia
  • Elective Caesarean section
  • non-invasive haemodynamic parameters
03

In context

Hypotension

1,023 studies on the registry are indexed under Hypotension; 172 are open to participants now.

This study's enrollment of 55 is below the median of 84 across 301 observational studies indexed under Hypotension.

Browse Hypotension studies →

Lead sponsor

Papa Giovanni XXIII Hospital is the lead sponsor of 22 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Healthy pregnant women admitted in the enrolling Centre to undergo to elective Caesarean section under spinal anaesthesia

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant women with high bleeding risk (previous caesarean section, previous uterine surgery, placenta praevia/accrete, previous documented uterine atony, foetal macrosomia, polyhydramnios)
  • Obstetric nulliparous or multiparous patients
  • Spontaneous pregnancy
  • Single foetus, at term
  • Elective Caesarean section, fasting according to international guidelines
  • At term BMI > 18 and \< 35 kg/m2

Exclusion criteria

Exclusion Criteria:

  • Contraindications to neuraxial anaesthesia
  • Previous documented maternal cardiovascular problems
  • Gestational hypertension (defined as new onset systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg on two occasions at east 4 - 6 hours apart while the patient is on bed rest, with an appropriately sized cuff, after 20 weeks gestation)
  • Chronic hypertension of any causes (defined as systemic blood pressure > 140/90 mmHg)
  • Preeclampsia (defined as gestational hypertension with one or more of the following de novo conditions:

    • Proteinuria (defined as the excretion of 300 mg or more of protein in a 24-hour urine collection or a protein/creatinine ratio of at least 0.3 (each measured as mg/dL) or at least 1 g/L [2+] on dipstick testing)
    • Other maternal organ dysfunction:

      1. progressive renal insufficiency (renal creatinine concentration greater than 1.1 mg/dL or a doubling of the serum creatinine concentration in the absence of other renal disease),
      2. impaired liver function as indicated by abnormally elevated blood concentrations of liver enzymes (at least twice upper limit of normal concentration), severe persistent right upper quadrant or epigastric pain unresponsive to medication and not accounted for by alternative diagnoses, or both),
      3. new-onset cerebral or visual disturbances (examples include eclampsia, altered mental status, blindness, stroke, or more commonly hyperreflexia when accompanied by clonus, severe headaches when accompanied by hyperreflexia, persistent visual scotoma),
      4. haematological complications (thrombocytopenia - platelet count below 150,000/dL, disseminated intravascular coagulation (DIC), haemolysis).
  • Uteroplacental dysfunction with foetal growth restriction (less than fifth percentile)
  • Reversed end-diastolic flow on umbilical artery Doppler studies (IR > 0,5 at 24 week gestation)
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
55 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Stress tests and Systolic blood pressure

    to identify correlations among stress tests (supine, deep breath in supine, left lateral, deep breath in left lateral, standing, deep breath in standing, leg raising), non-invasive haemodynamic parameter detected (Systolic blood pressure in mmHg) and neuraxial anaesthesia induced hypotension (clinical end point)

    Time frame: before Caesarean section

  2. Stress tests and Diastolic blood pressure

    to identify correlations among stress tests (supine, deep breath in supine, left lateral, deep breath in left lateral, standing, deep breath in standing, leg raising), non-invasive haemodynamic parameter detected (Diastolic blood pressure in mmHg) and neuraxial anaesthesia induced hypotension (clinical end point)

    Time frame: before Caesarean section

  3. Stress tests and Mean arterial blood pressure

    to identify correlations among stress tests (supine, deep breath in supine, left lateral, deep breath in left lateral, standing, deep breath in standing, leg raising), non-invasive haemodynamic parameter detected (Mean arterial blood pressure in mmHg) and neuraxial anaesthesia induced hypotension (clinical end point)

    Time frame: before Caesarean section

  4. Stress tests and Heart rate

    to identify correlations among stress tests (supine, deep breath in supine, left lateral, deep breath in left lateral, standing, deep breath in standing, leg raising), non-invasive haemodynamic parameter detected (Heart rate in beats per minute) and neuraxial anaesthesia induced hypotension (clinical end point)

    Time frame: before Caesarean section

  5. Stress tests and Cardiac output

    to identify correlations among stress tests (supine, deep breath in supine, left lateral, deep breath in left lateral, standing, deep breath in standing, leg raising), non-invasive haemodynamic parameter detected (Cardiac output in L/min) and neuraxial anaesthesia induced hypotension (clinical end point)

    Time frame: before Caesarean section

  6. Stress tests and Stroke volume

    to identify correlations among stress tests (supine, deep breath in supine, left lateral, deep breath in left lateral, standing, deep breath in standing, leg raising), non-invasive haemodynamic parameter detected (Stroke volume in mL/beat) and neuraxial anaesthesia induced hypotension (clinical end point)

    Time frame: before Caesarean section

  7. Stress tests and Systemic vascular resistance

    to identify correlations among stress tests (supine, deep breath in supine, left lateral, deep breath in left lateral, standing, deep breath in standing, leg raising), non-invasive haemodynamic parameter detected (Systemic vascular resistance in dynes - sec/cm\^5) and neuraxial anaesthesia induced hypotension (clinical end point)

    Time frame: before Caesarean section

Secondary outcomes

  1. Neuraxial induced hypotension

    Neuraxial induced hypotension is defined as a reduction of SBP \< 100 mmHg or a decrease by 20 - 30%, compared to basal value

    Time frame: from immediately after induction of spinal anaesthesia to 15 minutes later

07

Study locations

1 site
  • Asst Papa Giovanni Xxiii
    Bergamo, 24127, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 4, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03653442
Lead sponsor
Papa Giovanni XXIII Hospital
Responsible party
Chiara Viviani (Principal Investigator, Papa Giovanni XXIII Hospital) — Principal investigator
First posted
Aug 31, 2018
Start date
Jun 10, 2018
Primary completion
Dec 1, 2019
Completion
Jan 1, 2020
Last update
Mar 4, 2020

Study contacts

Chiara Viviani, M.D.
principal investigator · A.O. Ospedale Papa Giovanni XXIII

Oversight

FDA-regulated drug
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion